2012
DOI: 10.3389/fpsyg.2012.00443
|View full text |Cite
|
Sign up to set email alerts
|

Attitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers

Abstract: Objectives: In Switzerland, assisted suicide (AS) is legal, provided that the person seeking assistance has decisional capacity and the person assisting is not motivated by reasons of self-interest. However, in this particular setting nothing is known about patients’ and their caregivers’ attitudes toward AS and life-prolonging measures. Methods: Data was retrieved through validated questionnaires and personal interviews in 33 patients and their caregivers covering the following domains: physical function acco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
13
0
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 34 publications
3
13
0
2
Order By: Relevance
“…18 A significant number of the ALS cohort did not take the medication, possibly using the prescription as a safeguard against continued loss of autonomy. Compared to the 9 patients in the Washington cohort who did not take the medication and died naturally of the disease, more patients who used the medication had bulbar onset, were more concerned about being a burden on family, caregiver, and friends, and were less religious, consistent with previous studies in patients with ALS reporting their wish to participate in either euthanasia or assisted suicide in both Europe 19 and the United States. 20 Despite the best efforts of experienced ALS clinicians, predicting a 6-month survival for patients with ALS is challenging.…”
Section: Discussionsupporting
confidence: 76%
“…18 A significant number of the ALS cohort did not take the medication, possibly using the prescription as a safeguard against continued loss of autonomy. Compared to the 9 patients in the Washington cohort who did not take the medication and died naturally of the disease, more patients who used the medication had bulbar onset, were more concerned about being a burden on family, caregiver, and friends, and were less religious, consistent with previous studies in patients with ALS reporting their wish to participate in either euthanasia or assisted suicide in both Europe 19 and the United States. 20 Despite the best efforts of experienced ALS clinicians, predicting a 6-month survival for patients with ALS is challenging.…”
Section: Discussionsupporting
confidence: 76%
“…14 It is quite obvious that both ALS patients and members of their families often need active psychological nursing and sometimes consultation of the psychiatrist or narcologist. 15 If a patient with ALS takes the drug Riluzole metabolized by cytochrome CYP2А1 and causing drug-induced hepatitis in 3-12% of cases, it is necessary that the patient have reduced the number of cigarettes a day, as smoking intensifies the work of this cytochrome, and abstained from strong alcoholic beverages for achievement of the maximal activity of the drug and minimization of adverse effects. 1,9 The analysis of correlation of frontotemporal cognitive, cognitive, bulbar disorders and administration of cholinolytics, which have not been earlier performed in the international and domestic literature, deserves special attention.…”
Section: Discussionmentioning
confidence: 99%
“…Тревога приводит к существенному нарушению образа жизни с развитием злоупотребления лекарственными препарата-ми, отказу от сотрудничества с врачами и обращению к представителям нетрадиционной медицины. Все это сви-детельствует о том, что не только больные БАС, но и чле-ны их семей нуждаются в активном психологическом па-тронаже, в некоторых случаях консультации психиатра или нарколога [13,14].…”
Section: Discussionunclassified